Challenges and Future Trends of COVID-19 Vaccination
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "COVID-19 Vaccines and Vaccination".
Deadline for manuscript submissions: closed (31 August 2023) | Viewed by 32897
Special Issue Editor
Interests: child and maternal health
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
It is now over two years since the WHO declared COVID-19 a pandemic. More than six million deaths due to COVID-19 have been officially reported. The virus has caused unprecedented disruption and harm to billions of lives and livelihoods around the world. Fortunately, the wide range of safe and effective vaccines for COVID-19 developed in record time can mitigate the worst impacts of this pandemic. These vaccines have remained highly effective at reducing serious illness and deaths. Even as the virus continues to mutate, vaccination continues to provide the best defense against COVID-19, protecting against hospitalization and severe disease, slowing transmission, and reducing the risk of future variants.
For much of 2020 and 2021, securing access to scarce supplies of COVID-19 vaccines was an overriding priority for most countries and helped drive global inequalities in terms of vaccine coverage. However, whilst substantial progress has been made in supply, the delivery of COVID-19 vaccines at a global and national level remains unequal and falls short of the expectations set out during 2020 and 2021. During much of that period, a combination of supply shortages, manufacturing challenges, intense competition for vaccines, export bans, and delays to regulatory approvals has meant that many low- and lower-middle income countries were left behind as deliveries of COVID-19 vaccines increased in higher-income countries. While some high-income countries have vaccinated more than 70% of their population, many LMICs has vaccinated less than their 10% populations so far.
We are pleased to invite you to submit your original manuscripts, reviews, position papers, and case studies which discuss implementation, surveillance, research, programs, improving the equity of COVID-19 vaccination, policies related to COVID-19 vaccination, and social and behavioral science strategies supporting vaccine acceptance. We especially welcome submissions exploring vaccination amongst diverse and marginalized communities that have been acutely affected by the COVID-19 pandemic. Submissions dealing with lessons learned from the past and current health crises relating to pandemic preparedness in the future will also be considered.
We look forward to receiving your contributions.
Dr. Imran Raza Mirza
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccines
- COVID-19
- SARS-CoV-2
- vaccine confidence
- risk communication
- vaccine hesitancy
- pandemic
- vaccination
- challenges
- lessons learned
- routine immunization
- pandemic